Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
about
Clinical applications of the continuous flow blood separator machine.Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.Granuloma formation in patients receiving BCG immunotherapy.Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.Long survival in acute myelogenous leukaemia.Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
P2860
Q33145867-92BBCFD1-8FA7-4CA5-B026-78047855B225Q36043517-3D1FD57E-AE0B-4B28-8529-4DC2D9B64ECAQ36068946-0FAF2FCD-61FA-46A5-9BFC-0B433F4D9948Q36600931-F69BAFF5-9B84-41E4-9ED8-39BC5AA751D3Q39879831-28F06857-B5B7-4A3D-A119-7A1E5C222A50Q40521351-D391A710-331D-4DBB-9AAF-959553449B77Q40570038-DA57D66C-123F-4A80-8892-60A94964BD71Q42152021-4D4FB72D-7B7F-419E-A0D5-0F1AA42E96D6Q42352704-57BC00AE-0C0B-4969-AFEE-E4774C4F851CQ42577997-CBE2330D-A455-476D-B22A-5908BCF083AB
P2860
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh
1973年學術文章
@zh-hant
name
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@en
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@nl
type
label
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@en
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@nl
prefLabel
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@en
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@nl
P2093
P2860
P356
P1433
P1476
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
@en
P2093
P2860
P304
P356
10.1136/BMJ.4.5892.571
P407
P577
1973-12-01T00:00:00Z